Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lund

Showing results (761-770 of 826) with videos related to

Pageof 83
Sort By:
European Journal of Heart Failure|December 10, 2019
European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose-lowering drugs in patients with heart failurePetar M Seferović, Andrew J S Coats, Piotr Ponikowski, et al.
Journal of the American College of Cardiology|September 25, 2024
Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and HyperkalemiaBertram Pitt, Stefan D Anker, Lars H Lund, et al.
European Journal of Heart Failure|September 10, 2023
Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE-HF modelPascal M Burger, Gianluigi Savarese, Jasper Tromp, et al.
ESC Heart Failure|December 22, 2022
Sex-related differences in left ventricular assist device utilization and outcomes: results from the PCHF-VAD registrySumant P Radhoe, Nina Jakus, Jesse F Veenis, et al.
European Journal of Heart Failure|May 23, 2024
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESCGianluigi Savarese, Felix Lindberg, Antonio Cannata, et al.
European Journal of Heart Failure|May 1, 2021
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of CardiologyGiuseppe M C Rosano, Brenda Moura, Marco Metra, et al.
International Journal of Cardiology|May 1, 2014
Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensusM S Nieminen, J Altenberger, T Ben-Gal, et al.
British Journal of Cancer|August 18, 2023
Histopathology and levels of proteins in plasma associate with survival after colorectal cancer diagnosisMagnus I Magnusson, Bjarni A Agnarsson, Jon G Jonasson, et al.
European Journal of Heart Failure|June 20, 2020
Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trialAdriaan A Voors, Jean-François Tamby, John G Cleland, et al.
Nature Communications|September 15, 2019
Selective autophagy maintains centrosome integrity and accurate mitosis by turnover of centriolar satellitesSøs Grønbæk Holdgaard, Valentina Cianfanelli, Emanuela Pupo, et al.
Pageof 83

Showing results (761-770 of 826) with videos related to

Sort By:
Pageof 83
European Journal of Heart Failure|December 10, 2019
European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose-lowering drugs in patients with heart failurePetar M Seferović, Andrew J S Coats, Piotr Ponikowski, et al.
Journal of the American College of Cardiology|September 25, 2024
Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and HyperkalemiaBertram Pitt, Stefan D Anker, Lars H Lund, et al.
European Journal of Heart Failure|September 10, 2023
Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE-HF modelPascal M Burger, Gianluigi Savarese, Jasper Tromp, et al.
ESC Heart Failure|December 22, 2022
Sex-related differences in left ventricular assist device utilization and outcomes: results from the PCHF-VAD registrySumant P Radhoe, Nina Jakus, Jesse F Veenis, et al.
European Journal of Heart Failure|May 23, 2024
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESCGianluigi Savarese, Felix Lindberg, Antonio Cannata, et al.
European Journal of Heart Failure|May 1, 2021
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of CardiologyGiuseppe M C Rosano, Brenda Moura, Marco Metra, et al.
International Journal of Cardiology|May 1, 2014
Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensusM S Nieminen, J Altenberger, T Ben-Gal, et al.
British Journal of Cancer|August 18, 2023
Histopathology and levels of proteins in plasma associate with survival after colorectal cancer diagnosisMagnus I Magnusson, Bjarni A Agnarsson, Jon G Jonasson, et al.
European Journal of Heart Failure|June 20, 2020
Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trialAdriaan A Voors, Jean-François Tamby, John G Cleland, et al.
Nature Communications|September 15, 2019
Selective autophagy maintains centrosome integrity and accurate mitosis by turnover of centriolar satellitesSøs Grønbæk Holdgaard, Valentina Cianfanelli, Emanuela Pupo, et al.
Pageof 83